Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s728, 2026. DOI: 10.25251/wx06pe13. Disponível em: https://skin.dermsquared.com/skin/article/view/4041. Acesso em: 2 may. 2026.